178 related articles for article (PubMed ID: 17420214)
1. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.
Lebeau I; Andrei G; Krecmerová M; De Clercq E; Holy A; Snoeck R
Antimicrob Agents Chemother; 2007 Jun; 51(6):2268-73. PubMed ID: 17420214
[TBL] [Abstract][Full Text] [Related]
2. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
Duraffour S; Snoeck R; Krecmerová M; van Den Oord J; De Vos R; Holy A; Crance JM; Garin D; De Clercq E; Andrei G
Antimicrob Agents Chemother; 2007 Dec; 51(12):4410-9. PubMed ID: 17893157
[TBL] [Abstract][Full Text] [Related]
3. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272
[TBL] [Abstract][Full Text] [Related]
5. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
6. Activities of various compounds against murine and primate polyomaviruses.
Andrei G; Snoeck R; Vandeputte M; De Clercq E
Antimicrob Agents Chemother; 1997 Mar; 41(3):587-93. PubMed ID: 9055998
[TBL] [Abstract][Full Text] [Related]
7. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
[TBL] [Abstract][Full Text] [Related]
8. Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position.
Krecmerová M; Masojídková M; Holý A
Bioorg Med Chem; 2010 Jan; 18(1):387-95. PubMed ID: 19914075
[TBL] [Abstract][Full Text] [Related]
9. New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity.
Krečmerová M; Dračínský M; Snoeck R; Balzarini J; Pomeisl K; Andrei G
Bioorg Med Chem; 2017 Sep; 25(17):4637-4648. PubMed ID: 28757102
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants.
Brunelle MN; Lucifora J; Neyts J; Villet S; Holy A; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2007 Jun; 51(6):2240-3. PubMed ID: 17371827
[TBL] [Abstract][Full Text] [Related]
11. Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.
Topalis D; Lebeau I; Krecmerová M; Andrei G; Snoeck R
Antimicrob Agents Chemother; 2011 May; 55(5):1961-7. PubMed ID: 21343444
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety.
Tichý T; Andrei G; Snoeck R; Balzarini J; Dračínský M; Krečmerová M
Eur J Med Chem; 2012 Sep; 55():307-14. PubMed ID: 22858222
[TBL] [Abstract][Full Text] [Related]
13. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R
Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144
[TBL] [Abstract][Full Text] [Related]
14. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
[TBL] [Abstract][Full Text] [Related]
15. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
16. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1278-303. PubMed ID: 23568857
[TBL] [Abstract][Full Text] [Related]
17. Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.
Baszczyňski O; Kaiser MM; Česnek M; Břehová P; Jansa P; Procházková E; Dračínský M; Snoeck R; Andrei G; Janeba Z
Antivir Chem Chemother; 2018; 26():2040206618813050. PubMed ID: 30497281
[TBL] [Abstract][Full Text] [Related]
18. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
19. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
Andrei G; Topalis D; De Schutter T; Snoeck R
Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
